Releaf
Lucy MacKinnon is a Senior Content Creator at Releaf, a health and technology company in the UK's medicinal cannabis sector, where efforts focus on transforming patient access and experience through a subscription service. Prior to this role, Lucy worked as a Journalist for The Cannavist, contributing to coverage of industry news and personal stories related to CBD and medicinal cannabis. Earlier experience includes serving as a Political Correspondent for Evade Magazine during university, where diverse writing styles were explored. Lucy holds a Bachelor of Arts in Journalism and Media Communications from De Montfort University, completed in 2018.
This person is not in the org chart
This person is not in any teams
Releaf
1 followers
Releaf, founded in 2022, is a healthcare company dedicated to transforming patient access to Cannabis Based Products for Medical use (CBPMs) in the UK. Despite the legalisation of medical cannabis in 2019, its uptake has been limited. An estimated 1.8 million people in the UK rely on illicit street cannabis for medical purposes, while over 20 million adults could benefit from CBPMs but are unaware of their options. Currently, only around 30,000 people in the UK have an active CBPM prescription. The primary obstacles to broader adoption are the complexity of the prescribing process and a lack of awareness among medical professionals and potential patients. Releaf has made significant investments in developing a HealthTech platform to streamline access to CBPMs for patients with various health conditions. The platform was launched in February 2024, eliminating previous barriers and bringing about fundamental changes in the UK's CBPM sector. Our Leadership Team has a proven track record in navigating complex, regulated markets. Through substantial investments in time, money, and expertise, we have developed Releaf's HealthTech operating platform. This platform simplifies the intricate and makes the opaque transparent, ensuring a seamless, single online session for patients to access CBPMs for their relevant conditions. Press enquiries: Press@releaf.co.uk